Liquisolid Tablets Formulation of Atorvastatin Calcium Using Polyethylene Glycol 400 as Solvent and Some Carrier Materials

Yulias Ninik  Windriyati; Matsniyyatul  Badriyah; Diar Arum  Kusumaningtyas; Rian Lesta  Riesmalia

doi:10.22146/ijp.1138

Yulias Ninik Windriyati Department of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Wahid Hasyim, Semarang 50236
Matsniyyatul Badriyah Department of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Wahid Hasyim, Semarang 50236
Diar Arum Kusumaningtyas Department of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Wahid Hasyim, Semarang 50236
Rian Lesta Riesmalia Department of Pharmaceutic and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Wahid Hasyim, Semarang 50236

Keywords: Atorvastatin calcium, Dissolution, Liquisolid tablets, Polyethylene Glycol 400

Abstract

The dissolution of atorvastatin calcium need to be improved since included BCS Class II drugs with low solubility and high permeability, meaning that the dissolution affects the bioavailability of drugs. This research aimed to develop a formulation of a liquisolid tablet using PEG 400 as a solvent and some carrier materials in various compositions to increase the dissolution of atorvastatin calcium. Different formulations of liquisolid tablets were conducted using different quantities of carrier and coating material for adsorbing liquid solvent to produce a free-flowing and compressible powder. Avicel PH 101, Avicel PH 102, Neusilin US2 were employed as the carrier and Aerosil 200 as the coating material. A disintegrant and lubricant were then added to the formed liquisolid system and compressed into tablets by the direct compressing method. The liquisolid tablets were characterized for their tableting properties and possible drug-excipient interaction by XRD and FTIR analysis. The tableting characteristics of atorvastatin calcium liquisolid tablets were within the acceptable limits criteria. The dissolution of AA4 and NA1 liquisolid tablets was higher compared to marketed tablets. Based on the XRD and FTIR analysis, no interactions between drug and excipient.

References

Baskaran, M., Talluri, K.B., Kuppusamy, G., Karri, V.V.S.R., and Kollipara, R. 2016). Formulation Development of Atorvastatin Calcium Tablets by Gel Liquisolid Compact Technique for Improving Solid State Stability and Dissolution Profile. Journal of Drug Research and Development. 2(4): 1-7.
Chouksey, R., Jain, A.K., Pandey, H., and Maithil, A. 2011. Development and bioavailability studies of atorvastatin nanoemulsion. International Journal of Pharmacy & Life Sciences, 2(8): 982–988.
Gozali, D., Putra, A.F.C., and Sopyan, I. 2014. Pengaruh modifikasi kristal kalsium atorvastatin terhadap laju disolusi. Bionatura-Jurnal Ilmu-imu Hayati dan Fisik. 16(2): 83-88.
Gozali, D., Wardhana, Y.W., and Shofa. 2015. Formulasi dan Evaluasi Tablet Dispersi Padat Kalsium Atorvastatin. Jurnal Pharmascience 2(2): 63–70.
Gubbi, S.R., & Jarag, R. 2010. Formulation and characterization of atorvastatin calcium liquisolid compacts. Asian Journal of Pharmaceutical Sciences. 5(2): 50–60.
Kadu, P.J., Kushare, S.S., Thacker, D.D., and Gattani, S.G. 2011. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems ( SEDDS ). Pharmaceutical Development and Technology. 16(1): 65–74. https://doi.org/10.3109/10837450903499333
Kearney, A.S., Crawford, L.F., Mehta, S.C., Radebaugh, G.W. 1993. The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor CI-981. Pharmaceutical Research 10(10): 1461-1465.
Khan, F.N., and Dehghan, M.H.G. 2011. Enhanced Bioavailability of Atorvastatin Calcium from Stabilized Gastric Resident Formulation, AAPS PharmSciTech. 12(4): 1077-1086. https://doi.org/10.1208/s12249-011-9673-3
Lu, M., Xing, H., Jiang, J., Chen, X., Yang, T., Wang, D., and Ding, P. 2017. Liquisolid technique and its applications in pharmaceutics. Asian Journal of Pharmaceutical Sciences, 12(2): 115–123. https://doi.org/10.1016/j.ajps.2016.09.007
Oishi, T. S., Nimmi, I., & Islam, S.M.A. 2011. Comparative in vitro Bioequivalence Analysis of Some Generic Tablets of Atorvastatin, a BCS Class II Compound. Bangladesh Pharmaceutical Journal. 14(1): 61–66.
Panghal, D., Nagpal, M., Thakur, G.S., and Arora, S. 2014. Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique. 82: 177-191. https://doi.org/10.3797/scipharm.1301-23
Popy, F.A., Dewan, I., and Islam, S.M.A. 2012. Evaluation of In Vitro Equivalence for Tablets Containing the Poorly Water- Soluble Compound Atorvastatin, Dissolution Technology. 19(4): 30–33.
Prabhu, P., and Patravale, V. 2016. Dissolution enhancement of atorvastatin calcium by co-grinding technique. Drug Delivery and Translational Research. 6(4): 380-391. https://doi.org/10.1007/s13346-015-0271-x
Rodde, M. S., Divase, G. T., Devkar, T. B., & Tekade, A. R. 2014. Solubility and Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin : In Vitro , Ex Vivo, and In Vivo Studies, BioMed Research International 2014.
Snela, A., Jadach, B., Froelich, A., Skotnicki, M., Milczewska, K., Rojewska, M., and Lulek, J. 2019. Self-emulsifying drug delivery systems with atorvastatin adsorbed on solid carriers : formulation and in vitro drug release studies. Colloids and Surfaces A, 577(2019): 281–290. https://doi.org/10.1016/j.colsurfa.2019.05.062
Sonje, V.M., Kumar, L. and Meena, C.L. 2010. Atorvastatin Calcium. in Kohli, G., Puri, V., & Jain, R. (Eds). Profiles of Drug Substances Excipients and Related Methodology 1st ed., Vol. 35. Elsevier Inc. https://doi.org/10.1016/S1871-5125(10)35001-1
Spireas, S. 2002, Liquisolid System and Methods of Preparing Same, Pharmaceutical Research, U.S.Pantent, 1 – 9
Vranikova, B., and Gajdziok, J. (2013). Liquisolid systems and aspects influencing their research and development, Acta Pharmaceutica 63: 447–465.
Vraníková, B., Gajdziok, J., & Vetchý, D. 2015. Modern Evaluation of Liquisolid Systems with Varying Amounts of LiquidPhase Prepared Using Two Different Methods, BioMed Research International 2015.
Wicaksono, Y., Wisudyaningsih, B., and Siswoyo, T.A. 2017a. Enhancement of solubility and dissolution rate of atorvastatin calcium by co-crystallization. Tropical Journal of Pharmaceutical Research. 16(7): 1497–1502.
Wicaksono, Y., Wisudyaningsih, B., Widiarthi, F. O., and Siswoyo, T. A. 2017b. Thermodynamic and Thermomicroscopy Study of Atorvastatin Calcium-Succinic Acid Binary Mixtures, Indonesian Journal Chemistry. 17(3): 485–490. https://doi.org/10.22146/ijc.25089
Yadav, V. B. and Yadav, A.V. 2009. Liquisolid granulation technique for tablet manufacturing : an overview. Journal of Pharmacy Research 2(4): 670–674.